A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapy

Diabetes Research and Clinical Practice

Volumn 72, Issue 3, 2006, Pages 238-243

  Matsuyoshi, Akiko ^a   Shimoda, Seiya ^a   Tsuruzoe, Kaku ^a   Taketa, Kayo ^a   Chirioka, Takeshi ^a   Sakamoto, Fumi ^a   Sakakida, Michiharu ^a   Miyamura, Nobuhiro ^a   Araki, Eiichi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Insulin antibody; Insulin autoimmune antibody; Insulin autoimmune syndrome (IAS); Steroid pulse therapy

Indexed keywords

GLICLAZIDE; INSULIN ANTIBODY; METHYLPREDNISOLONE; POLYCLONAL ANTIBODY; PREDNISOLONE; RECOMBINANT HUMAN INSULIN; STEROID;

AGED; ANAMNESIS; ANTIBODY TITER; ARTICLE; CASE REPORT; DISEASE COURSE; DRUG EFFECT; DRUG MEGADOSE; DRUG PULSE THERAPY; GLYCEMIC CONTROL; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; IMMUNOASSAY; INSULIN BINDING; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; HUMANS; INSULIN ANTIBODIES; MALE; PREDNISOLONE;

EID: 33646577189     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.10.018     Document Type: Article

References (18)

1. Van Haeften T.W. Clinical significance of insulin antibodies in insulin-treated diabetic patients. Diabetes Care 12 (1989) 641-648
2. Lahtela J.T., Knip M., Paul R., Antonen J., and Salmi J. Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. Diabetes Care 20 (1997) 71-73
3. Asai M., Kodera T., Ishizeki K., Uebori S., Kashiwaya T., Itoh H., et al. Insulin lispro reduces insulin antibodies in a patient with type 2 diabetes with immunological insulin resistance. Diabetes Res. Clin. Pract. 61 (2003) 89-92
4. Dahl-Jorgensen K., Torjesen P., Hanssen K.F., Sandvik L., and Aagenaes O. Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment. Diabetes 36 (1987) 1-5
5. Scatchard G. The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci. 51 (1949) 660-672
6. Uehara M., Kishikawa H., Isami S., Kisanuki K., Ohkubo Y., Miyamura N., et al. Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans. Diabetologia 37 (1994) 300-307
7. Eguchi Y. Scatchard analysis of insulin autoantibodies in the insulin autoimmune syndrome. Tokyo Joshi Ikadaigaku Zasshi 59 (1989) 1296-1305 (in Japanese)
8. 131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects. J. Clin. Invest. 35 (1956) 170-190
9. Kurtz A.B., Gray R.S., Markanday S., and Nabarro J.D. Circulating IgG antibody to protamine in patients treated with protamine-insulins. Diabetologia 25 (1983) 322-324
10. Vaitukaitis J., Robbins J.B., Nieschlag E., and Ross G.T. A method for producing specific antisera with small doses of immunogen. J. Clin. Endocrinol. Metab. 33 (1971) 988-991
11. Reeves W.G., Barr D., Douglas C.A., Gelsthorpe K., Hanning I., Skene A., et al. Factors governing the human immune response to injected insulin. Diabetologia 26 (1984) 266-271
12. Hirata Y., and Uchigata Y. Insulin autoimmune syndrome in Japan. Diabetes Res. Clin. Pract. 24 Suppl (1994) S153-S157
13. Hirata Y., Ishizu H., Motomura M., Abe M., Hara Y., Wakasugi H., et al. Insulin autoimmunity in a case of spontaneous hypoglycemia. J. Jpn. Diabetes 13 (1970) 312-320 (in Japanese)
14. Uchigata Y., Tokunaga K., Nepom G., Bannai M., Kuwata S., Dozio N., et al. Differential immunogenetic determinants of polyclonal insulin autoimmune syndrome (Hirata's disease) and monoclonal insulin autoimmune syndrome. Diabetes 44 10 (1995) 1227-1232
15. Matsushita S., Takahashi K., Motoki M., Komoriya K., Ikagawa S., and Nishimura Y. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J. Exp. Med. 180 3 (1994) 873-883
16. Kobayashi T., Tamemoto K., Nakanishi K., Kato N., Okubo M., Kajio H., et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16 (1993) 780-788
17. Micic D., Brkic S., Kendereski A., Popovic V., Zoric S., Nikolic J.A., et al. Immunological resistance to human biosynthetic insulin-effects of immunosuppression and plasmapheresis. Diabetes Res. Clin. Pract. 19 (1993) 83-89
18. Miyamura N., Murata Y., Taketa K., Ichihara Y., Matsumura T., Tokunaga H., et al. A case of insulin autoimmune syndrome with HLA DRB1*0404: impact on the hypothesis for the molecular pathogenesis involving the DRB1 molecules. Diabetes Med. 23 (2006) 104-105